CN114317474B - Glutathione S-transferase mutant with improved enzyme activity and application thereof - Google Patents
Glutathione S-transferase mutant with improved enzyme activity and application thereof Download PDFInfo
- Publication number
- CN114317474B CN114317474B CN202111341341.1A CN202111341341A CN114317474B CN 114317474 B CN114317474 B CN 114317474B CN 202111341341 A CN202111341341 A CN 202111341341A CN 114317474 B CN114317474 B CN 114317474B
- Authority
- CN
- China
- Prior art keywords
- slgst
- mutant
- glutathione
- seq
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 27
- 102000005720 Glutathione transferase Human genes 0.000 title claims abstract description 24
- 108010070675 Glutathione transferase Proteins 0.000 title claims abstract description 24
- 230000000694 effects Effects 0.000 title abstract description 19
- 150000001413 amino acids Chemical group 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 40
- 238000005520 cutting process Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000013613 expression plasmid Substances 0.000 claims description 8
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 230000014509 gene expression Effects 0.000 claims description 7
- 238000003259 recombinant expression Methods 0.000 claims description 6
- 229960003180 glutathione Drugs 0.000 claims description 4
- 108010024636 Glutathione Proteins 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 238000012257 pre-denaturation Methods 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 239000013612 plasmid Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 5
- 230000009465 prokaryotic expression Effects 0.000 abstract description 4
- 238000001742 protein purification Methods 0.000 abstract description 3
- 238000002741 site-directed mutagenesis Methods 0.000 abstract description 3
- 239000004475 Arginine Substances 0.000 abstract description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 2
- 239000004472 Lysine Substances 0.000 abstract description 2
- 235000004279 alanine Nutrition 0.000 abstract description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 description 18
- 235000018102 proteins Nutrition 0.000 description 16
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 15
- 240000003768 Solanum lycopersicum Species 0.000 description 14
- 239000000047 product Substances 0.000 description 11
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 230000035772 mutation Effects 0.000 description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000013598 vector Substances 0.000 description 5
- 235000002560 Solanum lycopersicum Nutrition 0.000 description 4
- 241001052560 Thallis Species 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000009210 therapy by ultrasound Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 2
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 2
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 2
- OSRZOHXQCUFIQG-FPMFFAJLSA-N Ala-Phe-Pro Chemical compound C([C@H](NC(=O)[C@@H]([NH3+])C)C(=O)N1[C@H](CCC1)C([O-])=O)C1=CC=CC=C1 OSRZOHXQCUFIQG-FPMFFAJLSA-N 0.000 description 2
- CQJHFKKGZXKZBC-BPNCWPANSA-N Ala-Pro-Tyr Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CQJHFKKGZXKZBC-BPNCWPANSA-N 0.000 description 2
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 2
- VNFSAYFQLXPHPY-CIQUZCHMSA-N Ala-Thr-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNFSAYFQLXPHPY-CIQUZCHMSA-N 0.000 description 2
- DFCIPNHFKOQAME-FXQIFTODSA-N Arg-Ala-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFCIPNHFKOQAME-FXQIFTODSA-N 0.000 description 2
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 2
- LVHMEJJWEXBMKK-GMOBBJLQSA-N Asn-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N LVHMEJJWEXBMKK-GMOBBJLQSA-N 0.000 description 2
- NLRJGXZWTKXRHP-DCAQKATOSA-N Asn-Leu-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NLRJGXZWTKXRHP-DCAQKATOSA-N 0.000 description 2
- XMHFCUKJRCQXGI-CIUDSAMLSA-N Asn-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O XMHFCUKJRCQXGI-CIUDSAMLSA-N 0.000 description 2
- CBHVAFXKOYAHOY-NHCYSSNCSA-N Asn-Val-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O CBHVAFXKOYAHOY-NHCYSSNCSA-N 0.000 description 2
- WSOKZUVWBXVJHX-CIUDSAMLSA-N Asp-Arg-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O WSOKZUVWBXVJHX-CIUDSAMLSA-N 0.000 description 2
- PXLNPFOJZQMXAT-BYULHYEWSA-N Asp-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O PXLNPFOJZQMXAT-BYULHYEWSA-N 0.000 description 2
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 2
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 2
- DWDBJWAXPXXYLP-SRVKXCTJSA-N Gln-His-Arg Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N DWDBJWAXPXXYLP-SRVKXCTJSA-N 0.000 description 2
- XZUUUKNKNWVPHQ-JYJNAYRXSA-N Gln-Phe-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O XZUUUKNKNWVPHQ-JYJNAYRXSA-N 0.000 description 2
- VNTGPISAOMAXRK-CIUDSAMLSA-N Gln-Pro-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O VNTGPISAOMAXRK-CIUDSAMLSA-N 0.000 description 2
- FKGNJUCQKXQNRA-NRPADANISA-N Glu-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O FKGNJUCQKXQNRA-NRPADANISA-N 0.000 description 2
- QJCKNLPMTPXXEM-AUTRQRHGSA-N Glu-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O QJCKNLPMTPXXEM-AUTRQRHGSA-N 0.000 description 2
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 2
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 2
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 2
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 2
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 2
- XINDHUAGVGCNSF-QSFUFRPTSA-N His-Ala-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XINDHUAGVGCNSF-QSFUFRPTSA-N 0.000 description 2
- KWBISLAEQZUYIC-UWJYBYFXSA-N His-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)N KWBISLAEQZUYIC-UWJYBYFXSA-N 0.000 description 2
- FOCSWPCHUDVNLP-PMVMPFDFSA-N His-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC4=CN=CN4)N FOCSWPCHUDVNLP-PMVMPFDFSA-N 0.000 description 2
- RGSOCXHDOPQREB-ZPFDUUQYSA-N Ile-Asp-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N RGSOCXHDOPQREB-ZPFDUUQYSA-N 0.000 description 2
- FUOYNOXRWPJPAN-QEWYBTABSA-N Ile-Glu-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N FUOYNOXRWPJPAN-QEWYBTABSA-N 0.000 description 2
- JLWLMGADIQFKRD-QSFUFRPTSA-N Ile-His-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CN=CN1 JLWLMGADIQFKRD-QSFUFRPTSA-N 0.000 description 2
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 2
- GAZGFPOZOLEYAJ-YTFOTSKYSA-N Ile-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N GAZGFPOZOLEYAJ-YTFOTSKYSA-N 0.000 description 2
- VOCZPDONPURUHV-QEWYBTABSA-N Ile-Phe-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VOCZPDONPURUHV-QEWYBTABSA-N 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- ZRLUISBDKUWAIZ-CIUDSAMLSA-N Leu-Ala-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O ZRLUISBDKUWAIZ-CIUDSAMLSA-N 0.000 description 2
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 2
- CUXRXAIAVYLVFD-ULQDDVLXSA-N Leu-Arg-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CUXRXAIAVYLVFD-ULQDDVLXSA-N 0.000 description 2
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 2
- GBDMISNMNXVTNV-XIRDDKMYSA-N Leu-Asp-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GBDMISNMNXVTNV-XIRDDKMYSA-N 0.000 description 2
- FQZPTCNSNPWHLJ-AVGNSLFASA-N Leu-Gln-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O FQZPTCNSNPWHLJ-AVGNSLFASA-N 0.000 description 2
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 2
- AKVBOOKXVAMKSS-GUBZILKMSA-N Leu-Ser-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O AKVBOOKXVAMKSS-GUBZILKMSA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 2
- NDORZBUHCOJQDO-GVXVVHGQSA-N Lys-Gln-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O NDORZBUHCOJQDO-GVXVVHGQSA-N 0.000 description 2
- HKXSZKJMDBHOTG-CIUDSAMLSA-N Lys-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN HKXSZKJMDBHOTG-CIUDSAMLSA-N 0.000 description 2
- ZJSXCIMWLPSTMG-HSCHXYMDSA-N Lys-Trp-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZJSXCIMWLPSTMG-HSCHXYMDSA-N 0.000 description 2
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 2
- HMZPYMSEAALNAE-ULQDDVLXSA-N Lys-Val-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMZPYMSEAALNAE-ULQDDVLXSA-N 0.000 description 2
- VOOINLQYUZOREH-SRVKXCTJSA-N Met-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N VOOINLQYUZOREH-SRVKXCTJSA-N 0.000 description 2
- HLZORBMOISUNIV-DCAQKATOSA-N Met-Ser-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C HLZORBMOISUNIV-DCAQKATOSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- HTKNPQZCMLBOTQ-XVSYOHENSA-N Phe-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N)O HTKNPQZCMLBOTQ-XVSYOHENSA-N 0.000 description 2
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 2
- FGXIJNMDRCZVDE-KKUMJFAQSA-N Phe-Cys-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N FGXIJNMDRCZVDE-KKUMJFAQSA-N 0.000 description 2
- JWQWPTLEOFNCGX-AVGNSLFASA-N Phe-Glu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWQWPTLEOFNCGX-AVGNSLFASA-N 0.000 description 2
- FZHBZMDRDASUHN-NAKRPEOUSA-N Pro-Ala-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(O)=O FZHBZMDRDASUHN-NAKRPEOUSA-N 0.000 description 2
- CQZNGNCAIXMAIQ-UBHSHLNASA-N Pro-Ala-Phe Chemical compound C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O CQZNGNCAIXMAIQ-UBHSHLNASA-N 0.000 description 2
- BAKAHWWRCCUDAF-IHRRRGAJSA-N Pro-His-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CN=CN1 BAKAHWWRCCUDAF-IHRRRGAJSA-N 0.000 description 2
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 2
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 2
- UPLYXVPQLJVWMM-KKUMJFAQSA-N Ser-Phe-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UPLYXVPQLJVWMM-KKUMJFAQSA-N 0.000 description 2
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 2
- PRNGXSILMXSWQQ-OEAJRASXSA-N Thr-Leu-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PRNGXSILMXSWQQ-OEAJRASXSA-N 0.000 description 2
- VGYVVSQFSSKZRJ-OEAJRASXSA-N Thr-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=CC=C1 VGYVVSQFSSKZRJ-OEAJRASXSA-N 0.000 description 2
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 2
- YVXIAOOYAKBAAI-SZMVWBNQSA-N Trp-Leu-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 YVXIAOOYAKBAAI-SZMVWBNQSA-N 0.000 description 2
- IYHNBRUWVBIVJR-IHRRRGAJSA-N Tyr-Gln-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IYHNBRUWVBIVJR-IHRRRGAJSA-N 0.000 description 2
- XQVRMLRMTAGSFJ-QXEWZRGKSA-N Val-Asp-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XQVRMLRMTAGSFJ-QXEWZRGKSA-N 0.000 description 2
- KOPBYUSPXBQIHD-NRPADANISA-N Val-Cys-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KOPBYUSPXBQIHD-NRPADANISA-N 0.000 description 2
- WJVLTYSHNXRCLT-NHCYSSNCSA-N Val-His-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WJVLTYSHNXRCLT-NHCYSSNCSA-N 0.000 description 2
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 2
- 108010045023 alanyl-prolyl-tyrosine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 108010070643 prolylglutamic acid Proteins 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 108010029384 tryptophyl-histidine Proteins 0.000 description 2
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 2
- 108010073969 valyllysine Proteins 0.000 description 2
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- WTZUSCUIVPVCRH-SRVKXCTJSA-N Lys-Gln-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WTZUSCUIVPVCRH-SRVKXCTJSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001516 effect on protein Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000024428 response to biotic stimulus Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a glutathione S-transferase mutant with improved enzyme activity and application thereof. Mutant SlGST T1 of glutathione-S-transferase K228A,R230A The amino acid sequence is shown in SEQ ID NO. 3. The invention obtains a mutant SlGST T1 of glutathione S-transferase by mutating lysine (Lys) at the 228 th site and arginine (Arg) at the 230 th site into alanine (Ala) through site-specific mutagenesis K228A,R230A Glutathione S-transferase and mutant SlGST T1 thereof are obtained by prokaryotic expression and protein purification K228A,R230A Protein, and the mutant SlGST T1 is detected and found by enzyme activity K228A,R230A The enzyme activity is obviously improved. The invention can provide technical reference for further research aiming at glutathione S-transferase in the aspects of biochemistry and molecular biology.
Description
The technical field is as follows:
the invention belongs to the technical field of biology, and particularly relates to a glutathione S-transferase mutant SlGST T1 with improved enzyme activity K228A,R230A And applications thereof.
The background art comprises the following steps:
glutathione-S-transferase (GST) is a large multifunctional gene family, widely distributed in eukaryotes and prokaryotes, is a key enzyme participating in glutathione catalytic reaction, and plays a biological function in multiple aspects of plant growth and development, response to biotic and abiotic stress, detoxification, biosynthesis of hormones, redox, metabolism and the like, and the improvement of the level of GSTs is helpful for maintaining the steady state of cellular redox and protecting organisms from being damaged by pressure and endotoxin.
The invention content is as follows:
the first purpose of the invention is to provide a mutant SlGST T1 of glutathione-S-transferase K228A,R230A The amino acid sequence is shown in SEQ ID NO. 3.
The second purpose of the invention is to provide a mutant SlGST T1 coding for the mutant K228A,R230A The gene of (1).
The third purpose of the invention is to provide a mutant containing coding SlGST T1 K228A,R230A A recombinant expression plasmid of the gene of (1).
Preferably, the expression plasmid is the expression vector pET28a (+).
The fourth purpose of the invention is to provide a host expression cell containing the recombinant expression plasmid.
Preferably, the host expression cell is E.coli.
A fifth object of the invention is a mutant SlGST T1 K228A,R230A Application in catalyzing glutathione combination reaction.
The sixth purpose of the invention is to provide a method for obtaining mutant SlGST T1 K228A,R230A The method of encoding a gene of (1), comprising the steps of:
(1) Carrying out PCR by taking an SlGST T1 gene as a template and taking sequences shown in SEQ ID NO.4 and SEQ ID NO.5 as primers to obtain a first PCR product, wherein the nucleotide sequence of the SlGST T1 gene is shown in SEQ ID NO. 1;
(2) Carrying out PCR by taking the first PCR product as a template and taking the sequences shown in SEQ ID NO.4 and SEQ ID NO.6 as primers to obtain a mutant SlGST T1 containing an enzyme cutting site K228A,R230A The coding gene of (4).
The PCR program of steps (1) and (2) is: pre-denaturation at 98 ℃ for 3min; denaturation at 98 ℃ for 10s, annealing at 60 ℃ for 20s, extension at 72 ℃ for 60s,35 cycles; extension at 72 ℃ for 5min. The PCR system of the present invention is not particularly limited, and a conventional PCR system in the art may be used.
At present, no relevant report is available for improving the enzyme catalytic activity of glutathione S-transferase through site-directed mutagenesis, and the mutant SlGST T1 of the glutathione S-transferase is obtained by mutating lysine (Lys) at the 228 th site and arginine (Arg) at the 230 th site into alanine (Ala) through the site-directed mutagenesis K228A,R230A The glutathione S-transferase and the mutant SlGST T1 thereof are obtained by prokaryotic expression and protein purification K228A,R230A Protein, and the mutant SlGST T1 is detected and found by enzyme activity K228A ,R230A The enzyme activity is obviously improved. The invention can provide technical reference for further research aiming at glutathione S-transferase in the aspects of biochemistry and molecular biology.
Description of the drawings:
FIG. 1 shows SlGST T1-His and its mutant SlGST T1 in the examples of the present invention K228A,R230A His purified protein SDS-PAGE;
FIG. 2 is a comparison graph of enzyme activity measured by spectrophotometry in the examples of the present invention (a and b show that there is significant difference between the two groups of enzyme activity measured values, p is less than 0.05).
The specific implementation mode is as follows:
the following examples are further illustrative of the present invention and are not intended to be limiting thereof.
Mutant SlGST T1 of glutathione S-transferase of the invention K228A,R230A The amino acid sequence is shown in SEQ ID NO. 3. Mutant SlGST T1 K228A,R230A The amino acid sequence of the SlGST T1 is mutated into Ala from Lys at the 228 th site and Arg at the 230 th site; the amino acid sequence of the SlGST T1 is shown in SEQ ID NO. 2. The method of the mutation is not particularly limited in the present invention, and a point mutation is preferable. The SlGST T1 is preferably derived from tomatoes, the gene sequence is shown as SEQ ID No.1, 711 base sequences are totally obtained, the protein encoded by the gene contains 236 amino acids, and the corresponding gene number in the tomato genome is Solyc12g056250.2.
The construction of a mutant of glutathione S-transferase, slGST T1, of the present invention is described in detail below K228A,R230A And a method ofAnd (4) testing the activity.
Example 1
Mutant SlGST T1 of glutathione S-transferase K228A,R230A The gene is obtained by a PCR mode, and the primer for PCR comprises a primer pair containing a restriction enzyme cutting site and a downstream primer containing a mutation site; the sequences of the primer pairs containing the enzyme cutting sites are shown as SEQ ID NO.4 and 5 (the amino acids of the enzyme cutting sites are thickened and the lower horizontal lines are marked); the sequences of the primer pairs containing the mutation sites are shown as SEQ ID NO.4 and 6 (amino acids at the mutation sites are bold).
1. Sample preparation: the tomato variety selected is AC (Solanum lycopersicum. Mill. Cv. Ailsa-Craig).
2. Cloning of the SlGST T1 Gene
Extracting total RNA in tomato fruits by a conventional hot boric acid method, carrying out reverse transcription on the extracted total RNA into cDNA by a method provided by a kit PrimeScriptTM RT Master Mix (Perfect Real Time, RR036A, taKara), and reacting: mixing X μ L RNA (< 500 ng), 2 μ L5 Xmix, and Y μ L RNase Free water to make total volume 10 μ L, placing in 37 deg.C constant temperature water bath for 15min in water bath, heating in 85 deg.C metal bath for 5s, and cooling at 4 deg.C.
Designing a primer containing a nde I enzyme cutting site and a primer containing a mutation site according to the sequence of an SlGST T1 gene in a tomato genome (https:// solgenomics. Net/tools/blast), wherein the sequences of the primers are shown in a table 1;
TABLE 1 cloning of SlGST T1 K228A,R230A Primers required for genes
Using tomato cDNA as a template, firstly respectively carrying out PCR by using an upstream primer (SEQ ID NO. 4) containing an enzyme cutting site and a downstream primer (SEQ ID NO. 5) to obtain a product 1, then using the product 1 as the template, carrying out PCR by using the upstream primer (SEQ ID NO. 4) containing an enzyme cutting site gene and the downstream primer (SEQ ID NO. 6) containing a mutation site to obtain a mutant SlGST T1 containing the enzyme cutting site K228A,R230A And (4) PCR products.
And carrying out PCR amplification by using tomato cDNA as a template and using an upstream primer (SEQ ID NO. 4) and a downstream primer (SEQ ID NO. 5) containing enzyme cutting sites to obtain an amplification product of the SlGST T1 gene.
The PCR conditions were: pre-denaturation at 98 ℃ for 3min, followed by 35 cycles (denaturation at 98 ℃ for 10s, annealing at 60 ℃ for 20s, and extension at 72 ℃ for 60 s), and extension at 72 ℃ for 5min. After the PCR reaction was completed, the detection was performed by 1% agarose gel electrophoresis.
3. Construction of SlGST T1 expression Strain
Respectively amplifying product of SlGST T1 gene and SlGST T1 K228A,R230A The PCR product is recycled and is connected with a pET28a (+) vector to construct a recombinant expression plasmid, and the reaction system selected by the connection is an In-fusion reaction system (TaKara) optimization: purification RCR fragment,100ng; linear vector:200ng;5 XIn-Fusion HD Enzyme Premix, 2. Mu.L, according to the above volume plus Deionized water to 10. Mu.L. Corresponding negative controls: linear vector:1 mu L of the solution; 5 XIn-Fusion HD Enzyme Premix, 2. Mu.l; deinized water,7 μ L. pUC19 positive control: purification RCR fragment, 2. Mu.L of 2kb control insert; linear vector:1 μ L of pUC19control vector;5 × InFussion HD Enzyme Premix,2 μ L; deinized water:5 μ L. The connection program of the present invention: and (3) slightly and uniformly mixing the reaction system, placing the mixture at 50 ℃ for incubation for 15min, and then placing the mixture on ice to obtain a ligation product, wherein the ligation product can be subjected to next conversion or stored at-20 ℃ for later use. Transforming the ligation product into escherichia coli DH5 alpha competent cells, culturing for 1h (37 ℃,200 rpm) in 700 mu LLB culture medium, taking 400 mu L of bacterial liquid, coating the bacterial liquid on a solid LB plate containing 0.05mg/mL kanamycin, culturing overnight at 37 ℃, selecting positive colonies, carrying out PCR identification, sending the positive bacterial liquid to Guangzhou Ongke sequencing company for sequencing, transforming the plasmid with correct sequencing into escherichia coli BL21 (DE 3) competent cells, adding 50% sterile glycerol according to the proportion of 1 to PCR identification of the positive bacterial liquid, and preserving at low temperature (-80 ℃), so as to respectively obtain SlGST T1 and SlGST T1 K228A,R230A And (3) expressing the strain.
4. SlGST T1-His and SlGST T1 K228A,R230A Prokaryotic expression and purification of His
(1) Prokaryotic expression
Respectively will be respectively provided withSlGST T1 and SlGST T1 K228A,R230A The expression strain is subjected to amplification culture (37 ℃,200 rpm), when the concentration of the bacterial liquid reaches OD600 of 0.4-0.6, the bacterial liquid is cooled to 15 ℃, then protein inducer IPTG with the final concentration of 1mM is added for low-temperature induction (15 ℃,100 rpm), and the bacterial body is collected after culture for 18-20 h.
(2) Protein purification
Adding sterile water to suspend the thalli, centrifuging for 10min at 4 ℃ at 6 000g to remove a culture medium, adding a proper volume of protein extracting solution (20 mM Tris-HCl,500mM NaCl, pH 7.5) to suspend the thalli, and mixing the components according to the volume of bacterial liquid in a ratio of 1:1000 Triton-100 was added to improve the efficiency of protein extraction. After the thalli is fully suspended, the thalli is crushed for 1h (30 s of ultrasonic treatment and 30s of stopping treatment) by using a low-temperature ultrahigh-pressure continuous flow cell crusher, and a container containing bacterial liquid needs to be kept in a full ice bath during the ultrasonic treatment so as to prevent the activity of protein from being reduced due to heating of a probe in the ultrasonic treatment process. PMSF with the final concentration of 1mM is added after the ultrasonication is finished to inhibit the degradation of protein. 9 000g at 4 ℃ for 30min, the supernatant was passed through a membrane (0.45 μm), then Ni NTASuperflow Cartridges (QIAGEN) equilibrated with the protein extract were added to the protein solution, finally imidazole was added to a final concentration of 10mM, and the protein was allowed to bind to the filler by spinning at low temperature 4 ℃ for more than 2 h.
The supernatant of the protein after standing is firstly passed through a nickel column, finally, the filler is also transferred into the nickel column, after the supernatant is completely passed through the nickel column, 40mM imidazole (containing 20mM Tris-HCl,500mM NaCl and pH 7.5) is added to wash the impurity protein until the solution under flowing is detected to be protein-free by Coomassie brilliant blue G250 (Biyun day). The target protein was then eluted with 250mM imidazole (containing 20mM Tris-HCl,500mM NaCl, pH 7.5). Since imidazole has an effect on protein activity, the collected target protein solution was immediately centrifuged (4 ℃ C., 4 000g) with 50mM potassium phosphate buffer solution at pH7 through Sephadex G-25 desalting column (GE)) to replace imidazole in the protein. Finally storing the purified target protein in an ultra-low temperature refrigerator at-80 ℃, reserving part of purified protein and unpurified protein for running gel detection, and carrying out SlGST T1-His and mutant SlGST T1 thereof K228A,R230A the-His SDS-PAGE is shown in FIG. 1.
5. Activation of protein by spectrophotometryAnd (5) detecting sex. The kit of Suzhou Keming biotechnology limited company is selected to determine SlGST T1-His and mutant SlGST T1 thereof K228A,R230A The specific procedures for the activity of His are described in the kit (GST-2-W) of glutathione S-transferase (GST).
Definition of activity units: 1nmol/L CDNB is catalyzed to bind to GSH at 25 ℃ or 37 ℃ per minute per mg protein to 1 unit of enzyme activity. The calculation formula is as follows:
GST (nmol/min/mg prot) = (A2-A1) ÷ ε ÷ d × 109 × V anti-total ÷ (Cpr × V-like) ÷ T =230 × (A2-A1) ÷ Cpr
The results are shown in FIG. 2, and it can be seen from FIG. 2 that the mutant SlGST T1 K228A,R230A The activity of the protein is obviously higher than that of SlGST T1, and the mutation improves the enzyme activity of glutathione S-transferase by 14.35%.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and amendments can be made without departing from the principle of the present invention, and these modifications and amendments should also be considered as the protection scope of the present invention.
Sequence listing
<110> institute of agricultural quality standards and monitoring technology of Guangdong province academy of agricultural sciences
<120> glutathione S-transferase mutant with improved enzyme activity and application thereof
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 711
<212> DNA
<213> tomato (Solanum lycopersicum)
<400> 1
atgtctctca aagtttacgt cgatcgtctt tctcaacctt ctcgtgctat tctcatcttt 60
tgcaaattaa atggaattga atttgaagag gttaatattg atcttgctaa aggtcaacat 120
cgcactcctg aatatcaaga agttaatatc atgaagcaag taccagccat agttcatgat 180
acttttaagc ttttcgaaag tcatgcgatt cttagatatc tagcttctgc atttccggaa 240
actgctgatc attggtatcc aaaagatctg cagaaaagag caaatgtaga atgtgtcttg 300
gattggcacc atgctaactt acgtcgtggt tcagcgggat atgtctttaa cactatactg 360
gcacctgcat ttggattgcc tttgaatcca caagctgctg cagaaggtaa aaatctcctt 420
tctgcatctc ttgcaacgat tgacacctat tggctgcaga aagacggaag ctttttgctt 480
ggaaattccc aaccttccct tgcagatctt agcttagttt gtgagattat gcaactccag 540
tttcttgacg agaaggatcg tgagggtcta ttaagcccgc acaagaacgt gttgaagtgg 600
attgacgatg tgaagagtgc cacagcacct tatttcgatg aaatacatgc aactctcttc 660
aaagttagcg agatttttca gaagcagcga gctggtggag caagcagcta a 711
<210> 2
<211> 236
<212> PRT
<213> tomato (Solanum lycopersicum)
<400> 2
Met Ser Leu Lys Val Tyr Val Asp Arg Leu Ser Gln Pro Ser Arg Ala
1 5 10 15
Ile Leu Ile Phe Cys Lys Leu Asn Gly Ile Glu Phe Glu Glu Val Asn
20 25 30
Ile Asp Leu Ala Lys Gly Gln His Arg Thr Pro Glu Tyr Gln Glu Val
35 40 45
Asn Ile Met Lys Gln Val Pro Ala Ile Val His Asp Thr Phe Lys Leu
50 55 60
Phe Glu Ser His Ala Ile Leu Arg Tyr Leu Ala Ser Ala Phe Pro Glu
65 70 75 80
Thr Ala Asp His Trp Tyr Pro Lys Asp Leu Gln Lys Arg Ala Asn Val
85 90 95
Glu Cys Val Leu Asp Trp His His Ala Asn Leu Arg Arg Gly Ser Ala
100 105 110
Gly Tyr Val Phe Asn Thr Ile Leu Ala Pro Ala Phe Gly Leu Pro Leu
115 120 125
Asn Pro Gln Ala Ala Ala Glu Gly Lys Asn Leu Leu Ser Ala Ser Leu
130 135 140
Ala Thr Ile Asp Thr Tyr Trp Leu Gln Lys Asp Gly Ser Phe Leu Leu
145 150 155 160
Gly Asn Ser Gln Pro Ser Leu Ala Asp Leu Ser Leu Val Cys Glu Ile
165 170 175
Met Gln Leu Gln Phe Leu Asp Glu Lys Asp Arg Glu Gly Leu Leu Ser
180 185 190
Pro His Lys Asn Val Leu Lys Trp Ile Asp Asp Val Lys Ser Ala Thr
195 200 205
Ala Pro Tyr Phe Asp Glu Ile His Ala Thr Leu Phe Lys Val Ser Glu
210 215 220
Ile Phe Gln Lys Gln Arg Ala Gly Gly Ala Ser Ser
225 230 235
<210> 3
<211> 236
<212> PRT
<213> tomato (Solanum lycopersicum)
<400> 3
Met Ser Leu Lys Val Tyr Val Asp Arg Leu Ser Gln Pro Ser Arg Ala
1 5 10 15
Ile Leu Ile Phe Cys Lys Leu Asn Gly Ile Glu Phe Glu Glu Val Asn
20 25 30
Ile Asp Leu Ala Lys Gly Gln His Arg Thr Pro Glu Tyr Gln Glu Val
35 40 45
Asn Ile Met Lys Gln Val Pro Ala Ile Val His Asp Thr Phe Lys Leu
50 55 60
Phe Glu Ser His Ala Ile Leu Arg Tyr Leu Ala Ser Ala Phe Pro Glu
65 70 75 80
Thr Ala Asp His Trp Tyr Pro Lys Asp Leu Gln Lys Arg Ala Asn Val
85 90 95
Glu Cys Val Leu Asp Trp His His Ala Asn Leu Arg Arg Gly Ser Ala
100 105 110
Gly Tyr Val Phe Asn Thr Ile Leu Ala Pro Ala Phe Gly Leu Pro Leu
115 120 125
Asn Pro Gln Ala Ala Ala Glu Gly Lys Asn Leu Leu Ser Ala Ser Leu
130 135 140
Ala Thr Ile Asp Thr Tyr Trp Leu Gln Lys Asp Gly Ser Phe Leu Leu
145 150 155 160
Gly Asn Ser Gln Pro Ser Leu Ala Asp Leu Ser Leu Val Cys Glu Ile
165 170 175
Met Gln Leu Gln Phe Leu Asp Glu Lys Asp Arg Glu Gly Leu Leu Ser
180 185 190
Pro His Lys Asn Val Leu Lys Trp Ile Asp Asp Val Lys Ser Ala Thr
195 200 205
Ala Pro Tyr Phe Asp Glu Ile His Ala Thr Leu Phe Lys Val Ser Glu
210 215 220
Ile Phe Gln Ala Gln Ala Ala Gly Gly Ala Ser Ser
225 230 235
<210> 4
<211> 52
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
ccgcgcggca gccatatgat gtctctcaaa gtttacgtcg atcgtctttc tc 52
<210> 5
<211> 41
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
agtcatgcta gccatatgtt agctgcttgc tccaccagct c 41
<210> 6
<211> 54
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
agtcatgcta gccatatgtt agctgcttgc tccaccagct gcctgcgcct gaaa 54
Claims (9)
1. Mutant SlGST T1 of glutathione-S-transferase K228A,R230A The polypeptide is characterized in that the amino acid sequence is shown as SEQ ID NO. 3.
2. A mutant SlGST T1 encoding the mutant of claim 1 K228A,R230A The gene of (1).
3. A recombinant plasmid containing the coding mutant SlGST T1 of claim 2 K228A,R230A The recombinant expression plasmid of (1).
4. The recombinant expression plasmid of claim 3, wherein the expression plasmid is the expression vector pET28a (+).
5. A host expression cell comprising the recombinant expression plasmid of claim 3 or 4.
6. The host expression cell of claim 5, wherein the host expression cell is E.coli.
7. Mutant SlGST T1 as claimed in claim 1 K228A,R230A Application in catalyzing glutathione combination reaction.
8. Mutant SlGST T1 is obtained K228A,R230A The method of encoding a gene of (1), comprising the steps of:
(1) Carrying out PCR by taking an SlGST T1 gene as a template and taking sequences shown in SEQ ID NO.4 and SEQ ID NO.5 as primers to obtain a first PCR product, wherein the nucleotide sequence of the SlGST T1 gene is shown in SEQ ID NO. 1;
(2) Carrying out PCR by taking the first PCR product as a template and taking the sequences shown in SEQ ID NO.4 and SEQ ID NO.6 as primers to obtain a mutant SlGST T1 containing an enzyme cutting site K228A,R230A The coding gene of (1).
9. The method of claim 8, wherein the PCR of steps (1) and (2) is programmed by: pre-denaturation at 98 ℃ for 3min; denaturation at 98 ℃ for 10s, annealing at 60 ℃ for 20s, extension at 72 ℃ for 60s,35 cycles; extension at 72 ℃ for 5min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111341341.1A CN114317474B (en) | 2021-11-12 | 2021-11-12 | Glutathione S-transferase mutant with improved enzyme activity and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111341341.1A CN114317474B (en) | 2021-11-12 | 2021-11-12 | Glutathione S-transferase mutant with improved enzyme activity and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114317474A CN114317474A (en) | 2022-04-12 |
| CN114317474B true CN114317474B (en) | 2022-10-11 |
Family
ID=81045572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111341341.1A Active CN114317474B (en) | 2021-11-12 | 2021-11-12 | Glutathione S-transferase mutant with improved enzyme activity and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114317474B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136605A (en) * | 1994-08-26 | 2000-10-24 | Wisconsin Alumni Research Foundation | Glutathione S-transferase isoforms |
| CN104328092A (en) * | 2014-09-28 | 2015-02-04 | 邦泰生物工程(深圳)有限公司 | Glutathione synthetase mutant, encoding gene and application |
| CN104630172A (en) * | 2014-11-06 | 2015-05-20 | 南京大学 | Mutant of schistosoma japonicum glutathione-S-transferase and application thereof |
-
2021
- 2021-11-12 CN CN202111341341.1A patent/CN114317474B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136605A (en) * | 1994-08-26 | 2000-10-24 | Wisconsin Alumni Research Foundation | Glutathione S-transferase isoforms |
| CN104328092A (en) * | 2014-09-28 | 2015-02-04 | 邦泰生物工程(深圳)有限公司 | Glutathione synthetase mutant, encoding gene and application |
| CN104630172A (en) * | 2014-11-06 | 2015-05-20 | 南京大学 | Mutant of schistosoma japonicum glutathione-S-transferase and application thereof |
Non-Patent Citations (4)
| Title |
|---|
| A0A3Q7JBS2;UniProt;《UniProt》;20190410;序列部分 * |
| NCBI:XP_004252589.1;NCBI;《GenBank》;20180808;序列部分 * |
| Proteome-wide identification of non-histone lysine methylation in tomato during fruit ripening;Lu Xiao等;《Journal of Advanced Research》;20220224;表1,图5 * |
| 家蚕谷胱甘肽-S-转移酶E4基因的组织表达和序列特征及重组蛋白的酶活性分析;谭祥等;《蚕业科学》;20120815(第04期);摘要 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114317474A (en) | 2022-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113403290B (en) | Glucose oxidase mutant with improved thermal stability as well as coding gene and application thereof | |
| CN106497895A (en) | Leucine dehydrogenase mutant, encoding gene, carrier, engineering bacteria and its application | |
| CN113528408B (en) | A method and application for efficient deletion of large genomic fragments based on CRISPR-nCas3 system | |
| CN111394337A (en) | Class II V-type CRISPR protein L b2Cas12a and application thereof in gene editing | |
| CN109022449A (en) | Cucumber CsMLO1 gene and its silencing expression vector establishment method, application | |
| CN111235130A (en) | Class II type V CRISPR protein CeCas12a and its application in gene editing | |
| CN108018269B (en) | A fructansucrase mutant with improved thermostability | |
| CN113801857B (en) | NADH dehydrogenase mutant SlNOX with improved enzyme activity and application thereof | |
| CN110300801A (en) | The control of the protein-protein interaction of acid decarboxylase | |
| CN113151270A (en) | Promoter for efficiently expressing alkaline protease and application thereof | |
| CN114317474B (en) | Glutathione S-transferase mutant with improved enzyme activity and application thereof | |
| Kirino et al. | Molecular cloning and nucleotide sequence of 3-isopropylmalate dehydrogenase gene (leuB) from an extreme thermophile, Thermus aquaticus YT-1 | |
| CN110592084A (en) | A recombinant strain modified by rhtA gene promoter and its construction method and application | |
| CN107602707B (en) | A dcas9-ω fusion protein that specifically regulates the expression of exogenous genes of Bacillus subtilis and its application | |
| CN119709687B (en) | Tth DNA polymerase mutant and application thereof | |
| NL2035702B1 (en) | Trachinotus ovatus b cell lymphoma-2 gene, trachinotus ovatus b cell lymphoma-2 protein, plasmid, and application of trachinotus ovatus b cell lymphoma-2 gene | |
| CN116496379B (en) | Thermal stability Rnase inhiba mutant, preparation method and application | |
| CN110699337B (en) | Alpha-amylase mutant BasAmy-4 with improved specific activity as well as coding gene and application thereof | |
| CN117660418B (en) | A mango chitinase mutant with improved enzyme activity and its application | |
| CN106754768B (en) | A kind of lipoxygenase mutant with improved thermostability and construction method thereof | |
| CN116515792B (en) | MMLV reverse transcriptase mutant and application thereof | |
| CN113528409B (en) | A kind of engineering bacteria containing nCas3 single-stranded endonuclease, preparation method and application | |
| CN114507273B (en) | YH66_07020 protein and application of related biological material thereof in improving arginine yield | |
| CN113429467A (en) | Application of NPF7.6 protein in regulation and control of nitrogen tolerance of leguminous plant root nodule | |
| CN110938608A (en) | Aldehyde ketone reductase mutant, encoding gene and application of aldehyde ketone reductase mutant in synthesis of (S) -TCPE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |